Page last updated: 2024-09-02

11-hydroxyandrostenedione and Bone Loss, Osteoclastic

11-hydroxyandrostenedione has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Iichikawa, Y; Mizushima, Y; Nakagawa, M; Sato, F; Suzuki, Y	1

Other Studies

1 other study(ies) available for 11-hydroxyandrostenedione and Bone Loss, Osteoclastic

Article	Year
A primary adrenal steroid, 11beta-hydroxyandrostenedione, has an osteotropic effect and little androgenic activity. The Journal of steroid biochemistry and molecular biology, 2000, Nov-15, Volume: 74, Issue:4 Topics: Adrenal Glands; Alkaline Phosphatase; Androstenedione; Animals; Bone and Bones; Bone Marrow Cells; Bone Resorption; Cells, Cultured; Colony-Forming Units Assay; Dihydroxycholecalciferols; Female; Femur; Humans; Male; Mice; Organ Size; Osteoblasts; Osteocalcin; Ovariectomy; Prostate; Rats; Rats, Wistar	2000

Article

Year

A primary adrenal steroid, 11beta-hydroxyandrostenedione, has an osteotropic effect and little androgenic activity.

The Journal of steroid biochemistry and molecular biology, 2000, Nov-15, Volume: 74, Issue:4

Topics: Adrenal Glands; Alkaline Phosphatase; Androstenedione; Animals; Bone and Bones; Bone Marrow Cells; Bone Resorption; Cells, Cultured; Colony-Forming Units Assay; Dihydroxycholecalciferols; Female; Femur; Humans; Male; Mice; Organ Size; Osteoblasts; Osteocalcin; Ovariectomy; Prostate; Rats; Rats, Wistar

2000